论中医药在腹膜透析治疗中的地位和作用
<正>根据王海燕教授团队领衔完成的中国慢性肾脏疾病（chroinc kidney disease,CKD）多中心、横断面调查研究,我国的CKD患病率约为10.8%,基于此数据,约有1.195亿的CKD患者群体<sup>[1]</sup>。即使在得到最理想治疗干预的情况下,进展至终末期肾脏疾病（end stage renal diss,ESRD）据保守估计也有200<sup>2</sup>50例/百万人<sup>[2]</sup>,直接造成对肾透析治疗,包括腹膜透析（peritoneal dialysis,PD）...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2015-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57920781&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|